Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes

Journal of Parasitology

Volumn 83, Issue 1, 1997, Pages 70-75

  Ali, Nahid ^a   Afrin, Farhat ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; MONONUCLEAR CELL; NONHUMAN; PROMASTIGOTE; PROTECTION; RAT; VACCINE PRODUCTION; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; DRUG CARRIERS; FREUND'S ADJUVANT; HYPERSENSITIVITY, DELAYED; IMMUNIZATION, SECONDARY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MICE; MICE, INBRED BALB C; PROTOZOAN VACCINES; VACCINATION;

ANIMALIA; LEISHMANIA DONOVANI;

EID: 0030970746     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3284319     Document Type: Article

References (52)

1. BADARO, R., T. C. JONES, R. LORENCO, B. J. CERF, D. SAMPAIO, E. M. CARVALHO, H. ROCHA, R. TEIXEIRA, AND W. D. JOHNSON. 1986. A prospective study of visceral leishmaniasis in an endemic area of Brazil. Journal of Infectious Diseases 154: 639-649.
2. BASAK, S. K., B. SAHA, A. BHATTACHARYA, AND S. ROY. 1992. Immunobiological studies on experimental visceral leishmaniasis. II Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. European Journal of Immunology 22: 2041-2045.
3. BRADLEY, D. J. 1987. Genetics of susceptibility and resistance in the vertebrate host. In The leishmaniasis in biology and medicine, Vol. 2, W. Peters and R. Killick-Kendrick (eds.). Academic Press, London, U.K., p. 551-581.
4. BRETSCHER, P. A., G. WEI, J. N. MENON, AND H. BIELEFELDT-OHMANN. 1992. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257: 539-542.
5. CARVALHO, E. M., O. BACELLAR, A. BARRAL, R. BADARO, AND W. D. JOHNSON, JR. 1989. Antigen specific immunosuppression in visceral leishmaniasis is cell-mediated. Journal of Clinical Investigation 83: 860-864.
6. _, W. D. JOHNSON, E. BARRETO, P. D. MARSDEN, J. L. M. COSTA, S. REED, AND H. ROCHA. 1985. Cell-mediated immunity in American cutaneous and mucosal leishmaniasis. Journal of Immunology 135: 4144-4148.
7. CHAMPSI, J., AND D. MCMAHON-PRATT. 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infection and Immunity 52: 3272-3279.
8. FRIES, L. F., D. M. GORDON, R. L. RICHARDS, J. E. EGAN, M. R. HOLLINGDALE, M. GROSS, C. SILVERMAN, AND C. R. ALVING. 1992. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy. Proceedings of the National Academy of Sciences, USA 89: 358-362.
9. GHALIB, H. W., M. R. PIUVEZAM, Y. A. W. SKEIKY, M. SIDDIQ, F. A. HASHIM, A. M. EL-HASSAN, D. M. RUSSO, AND S. G. REED. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. Journal of Clinical Investigation 92: 324-329.
10. _, J. A. WHITTLE, M. KUBIN, F. A. HASHIM, A. M. EL-HASSAN, K. H. GRABSTEIN, G. TRINCHIERI, AND S. G. REED. 1995. IL-12 enhances Th1-type responses in human Leishmania donovani infections. Journal of Immunology 154: 4623-4629.
11. GHOSH, A. K., F. K. BHATTACHARYA, AND D. K. GHOSH. 1985. Leishmania donovani: Amastigote inhibition and mode of action of berberine. Experimental Parasitology 60: 404-413.
12. GREENBLATT, C. L. 1980. The present and future of vaccination for cutaneous leishmaniasis. In New developments with human and veterinary vaccines, A. Mizrahi, I. Hertman, M. A. Klingerg, and A. Kohn (eds.). Alan R. Liss, New York, New York, p. 258-285.
13. HALDAR, J. P., S. GHOSE, K. C. SAHA, AND A. C. GHOSE. 1983. Cell-mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis. Infection and Immunity 42: 702-707.
14. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Sciences USA 88: 7011-7015.
15. HO, M., T. K. SIONGOK, W. LYERLY, AND D. SMITH. 1982. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 76: 741-746.
16. HOLADAY, B. J., M. D. SADICK, Z. E. WANG, S. L. REINER, F. P. HEINZEL, T. G. PARSLOW, AND R. M. LOCKSLEY. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1-like and Th2-like cell lines. Journal of Immunology 147: 1653-1658.
17. HOLBROOK, T. W., J. A. COOK, AND B. W. PARKER. 1981. Immunization against Leishmania donovani: Glucan as an adjuvant with killed promastigotes. American Journal of Tropical Medicine and Hygiene 30: 762-768.
18. HOWARD, J. G. 1986. Immunological regulation and control of experimental leishmaniasis. International Review of Experimental Pathology 28: 79-116.
19. _, S. NICKLIN, C. HALE, AND F. Y. LIEW. 1982. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. Journal of Immunology 129: 2206-2212.
20. JAFFE, C. L., N. RACHAMIM, AND R. SARFSTEIN. 1990. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. Journal of Immunology 144: 699-706.
21. JARECKI-BLACK, J. C., A. B. GLASSMAN, AND E. R. JAMES. 1985. Adoptive transfer of vaccine-induced resistance to Leishmania donovani. American Journal of Tropical Medicine and Hygiene 34: 1095-1097.
22. KAHL, L. P., C. A. SCOTT, R. LELCHUK, G. GREGORIADIS, AND F. Y. LIEW. 1989. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. Journal of Immunology 142: 4441-4449.
23. KARP, C. L., S. H. EL-SAFI, T. A. WYNN, M. M. H. SATTI, A. M. KORDOJANI, F. A. HASHIM, M. HAG-ALI, F. A. NEVA, T. B. NUTMAN, AND D. L. SACKS. 1993. In vivo cytokine profiles in patients with kala-azar - Marked elevation of both interleukin 10 and interferon-γ. Journal of Clinical Investigation 91: 1644-1648.
24. KAYE, P. M., A. J. CURRY, AND J. M. BLACKWELL. 1991. Differential production of Th1 and Th2 derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. Journal of Immunology 146: 2763-2770.
25. LATIF, N., AND B. K. BACHHAWAT. 1984. The effect of surface charges of liposomes in immunopotentiation. Bioscience Reports 4: 99-107.
26. _, AND _. 1987. The effect of surface-coupled antigen of liposomes in immunopotentiation. Immunology Letters 15: 45-51.
27. _, AND C. MANDAL. 1987. Liposome as an adjuvant for the production of estradiol antibodies. Immunology Letters 15: 237-242.
28. LIEW, F. Y. 1992. Induction, regulation and function of T cell subsets in leishmaniasis. Chemical Immunology 54: 117-135.
29. _, C. HALE, AND J. G. HOWARD. 1985. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection. Journal of Immunology 135: 2095-2101.
30. - T cells that do not mediate cutaneous DTH. Journal of Immunology 132: 456-461.
31. LOCKSLEY, R. M., AND J. A. LOUIS. 1992. Immunology of leishmaniasis. Current Opinions in Immunology 4: 413-418.
32. LOWRY, O. H., N. J. ROSEBROUGH, A. L. FARR, AND R. J. RANDALL. 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265-275.
33. MAUEL, J., AND R. BEHIN. 1987. Immunity: Clinical and experimental. In The leishmaniasis in biology and medicine, Vol. 2, W. Peters and R. Killick-Kendrick (eds.). Academic Press, London, U.K., p. 731-739.
34. MAYBRINK, W., P. WILLIAMS, C. A. DACOSTA, P. A. MAGALHAES, M. N. MELO, M. DIAS, A. O. LIMA, M. S. M. MICHALICK, E. F. CARVALHO, G. C. BARROS, P. A. SESSA, AND J. T. A. DE ALENCAR. 1985. An experimental vaccine against American dermal leishmaniasis: Experience in the state of Espirito-Santo, Brazil. Annals of Tropical Medicine and Parasitology 79: 259-269.
35. MCCONVILLE, M. J., A. BACIC, G. F. MITCHELL, AND E. HANDMAN. 1987. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proceedings of the National Academy of Sciences USA 84: 8941-8945.
36. MITCHELL, G. F., J. M. CURTIS, AND E. HANDMAN. 1981. Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice. Australian Journal of Experimental Biology and Medical Science 59: 555-565.
37. MURRAY, H. W., H. MASUR, AND J. S. KEITHLY. 1982. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. Journal of Immunology 129: 344-350.
38. _, K. E. SQUIRES, C. DIEGO MIRALLES, M. Y. STOECKLE, A. M. GRANGER, A. GRANELLI-PIPERNO, AND C. BOGDAN. 1992. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. Journal of Immunology 148: 1858-1863.
39. NEOGY, A. B., A. NANDY, B. G. DASTIDAR, AND A. B. CHOWDHURY. 1987. Antibody kinetics in kala-azar in response to treatment. Annals of Tropical Medicine and Parasitology 81: 727-729.
40. RACHAMIM, N., AND C. L. JAFFE. 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Journal of Immunology 150: 2322-2331.
41. REINER, N. E., AND J. H. FINKE. 1983. Interleukin 2 deficiency in murine Leishmania donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. Journal of Immunology 131: 1487-1491.
42. RUSSELL, D. G., AND J. ALEXANDER. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. Journal of Immunology 140: 1274-1279.
43. SACKS, D. L., S. L. LAL, S. N. SHRIVASTAVA, J. BLACKWELL, AND F. A. NEVA. 1987. An analysis of T cell responsiveness in Indian kala-azar. Journal of Immunology 138: 908-913.
44. SCHURR, E., K. KIDANE, T. YEMANEBERHAN, AND F. WUNDERLICH. 1986. Cutaneous leishmaniasis in Ethiopia. I. Lymphocyte transformation and antibody titre. Tropenmedizin und Parasitologie 37: 403-408.
45. SCOTT, P. 1989. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Experimental Parasitology 68: 369-372.
46. _, E. PEARCE, P. NATOVITZ, AND A. SHER. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. Journal of Immunology 139: 221-227.
47. SQUIRES, K. E., R. D. SCHREIBER, M. J. MCELRATH, B. Y. RUBIN, S. L. ANDERSON, AND H. W. MURRAY. 1989. Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response. Journal of Immunology 143: 4244-4249.
48. STAUBER, L. A., E. M. FRANCHINO, AND J. GRUN. 1958. An eight day method for screening compounds against Leishmania donovani in the golden hamster. Journal of Protozoology 5: 269-273.
49. + cells in experimental visceral leishmaniasis. Journal of Immunology 140: 3971-3977.
50. TITUS, R. G., G. C. LIMA, H. D. ENGERS, AND J. A. LOUIS. 1984. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major specific delayed-type hypersensitivity. Journal of Immunology 133: 1594-1600.
51. WHITE, A. C., AND D. MCMAHON-PRATT. 1990. Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. Journal of Infectious Diseases 161: 1313.
52. ZWINGENBERGER, K., G. HARMS, C. PEDROSA, S. OMENA, B. SANDKAMP, AND S. K. NEIFER. 1990. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ production. Clinical Immunological Immunopathology 57: 242-249.